Discuss the mechanism of action and rationale for benefit of SGLT2 inhibitors as well as adverse effects.
Discuss growing evidence of SGTL2 inhibitors within diabetes and non-diabetes patients, including heart failure and chronic kidney disease.
Delineate appropriate patient populations for SGLT2 inhibitors based on evidence.